XML 88 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Operations and Significant Accounting Policies (Tables)
12 Months Ended
Sep. 30, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Schedule of Product Warranty Liability

The following is a summary of activity in accrued warranty expense at our continuing operations (in thousands):

 

 

 

Years Ended September 30,

 

 

 

2019

 

 

2018

 

 

2017

 

Beginning balance

 

$

644

 

 

$

710

 

 

$

417

 

Additions for warranties issued during the period

 

 

785

 

 

 

966

 

 

 

965

 

Reductions in the liability for payments made under

   the warranty

 

 

(693

)

 

 

(782

)

 

 

(429

)

Changes related to pre-existing warranties

 

 

(179

)

 

 

(250

)

 

 

(244

)

Currency translation adjustment

 

 

(1

)

 

 

 

 

 

1

 

Ending balance

 

$

556

 

 

$

644

 

 

$

710

 

 

Summary of Research, Development and Engineering Expense The following is a summary of our research, development and engineering expense (in thousands):

 

 

 

Years Ended September 30,

 

 

 

2019

 

 

2018

 

 

2017

 

Research, development and engineering

 

$

3,112

 

 

$

2,868

 

 

$

3,037

 

Grants earned

 

 

(44

)

 

 

(12

)

 

 

(299

)

Net research, development and engineering

 

$

3,068

 

 

$

2,856

 

 

$

2,738

 

 

Summary of Effect of Adoption of New Accounting Pronouncement

The following table summarizes the effects related to the adoption of ASU 2016-18 for the years ended September 30, 2018 and 2017:

 

 

 

September 30, 2018

 

 

September 30, 2017

 

 

 

As reported

 

 

As adjusted

 

 

As reported

 

 

As adjusted

 

Net cash provided by (used in) operating activities

 

$

6,790

 

 

$

(13,768

)

 

$

11,789

 

 

$

34,051

 

Effect of Exchange Rate Changes on Cash, Cash

   Equivalents and Restricted Cash

 

$

(1,455

)

 

$

(1,372

)

 

$

192

 

 

$

1,677

 

Net Increase (Decrease) in Cash, Cash Equivalents

   and Restricted Cash

 

$

7,210

 

 

$

(13,265

)

 

$

23,466

 

 

$

47,213

 

Cash, Cash Equivalents and Restricted Cash,

   Beginning of Period

 

$

51,121

 

 

$

75,761

 

 

$

27,655

 

 

$

28,548

 

Cash, Cash Equivalents and Restricted Cash, End of

   Period

 

$

58,331

 

 

$

62,496

 

 

$

51,121

 

 

$

75,761